The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The Prevalence and Predicting Factors of Temporomandibular Disorders in COVID-19 Infection: A Cross-Sectional Study
    Haddad, Camille
    Sayegh, Suzanna Maria
    El Zoghbi, Amine
    Lawand, Ghida
    Nasr, Lara
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [32] Fear of COVID-19 among the Indian youth: A cross-sectional study
    Gaur, Gaurav
    Sharma, Meenakshi
    Kundu, Meenu
    Sekhon, Harmehr
    Chauhan, Nidhi
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2021, 10 (01)
  • [33] Echocardiographic features of patients with COVID-19 infection: a cross-sectional study
    Barman, Hasan Ali
    Atici, Adem
    Tekin, Esra Aktas
    Baycan, Omer Faruk
    Alici, Gokhan
    Meric, Bengisu Keskin
    Sit, Omer
    Genc, Omer
    Er, Fahri
    Gungor, Baris
    Sahin, Irfan
    Turgut, Namigar
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (03) : 825 - 834
  • [34] Perceptions and beliefs on vaccination for COVID-19 in Delhi: A cross-sectional study
    Sharma, Abha
    Srivastava, Anshuman
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 151 - 154
  • [35] Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study
    Ozdemir, Huseyin Nezih
    Dere, Birgul
    Gokcay, Figen
    Gokcay, Ahmet
    NEUROLOGICAL SCIENCES, 2022, 43 (06) : 3489 - 3496
  • [36] Prevalence of Burnout Syndrome in COVID-19 and Non-COVID-19 Units in University Hospital: A Cross-Sectional Study
    Ulbrichtova, Romana
    Svihrova, Viera
    Tatarkova, Maria
    Svihra, Jan, Jr.
    Novak, Martin
    Hudeckova, Henrieta
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [37] Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: a web-based cross-sectional study
    Mudenda, Steward
    Hikaambo, Christabel Nang'andu
    Daka, Victor
    Chileshe, Misheck
    Mfune, Ruth Lindizyani
    Kampamba, Martin
    Kasanga, Maisa
    Phiri, Margaret
    Mufwambi, Webrod
    Banda, Michelo
    Phiri, Maureen Nkandu
    Mukosha, Moses
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [38] Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: A cross-sectional study
    Klib, Mohamad
    Alazki, Osama
    Nabhan, Ayman Issa
    Brakat, Aml M.
    Alafandi, Bana Zuhair
    Idres, Fatima Abdulmoain
    Almenchaf, Ruba
    Albakkar, Farah
    Ghandour, Munir
    Zahlout, Jaafar
    Tabsho, Somayya
    Mouazen, Samar
    PREVENTIVE MEDICINE REPORTS, 2024, 37
  • [39] COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study
    Tadesse, Tamrat Assefa
    Antheneh, Ashenafi
    Teklu, Ashenafi
    Teshome, Asres
    Alemayehu, Bemnet
    Belayneh, Alemu
    Abate, Dessale
    Abiye, Alfoalem Araba
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2022, 32 (06) : 1061 - 1070
  • [40] Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
    Nouchi, Agathe
    Chastang, Julie
    Miyara, Makoto
    Lejeune, Julie
    Soares, Andre
    Ibanez, Gladys
    Saadoun, David
    Morelot-Panzini, Capucine
    Similowski, Thomas
    Amoura, Zahir
    Boddaert, Jacques
    Caumes, Eric
    Bleibtreu, Alexandre
    Lorenzo, Alain
    Tubach, Florence
    Pourcher, Valerie
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (04) : 691 - 697